Windgap Medical, Inc.

Injecting simplicity into complex drug delivery

Founded 2011

Watertown, United States 19 employees Series B Total: $42.03M Biotechnology, Health Care +2

Windgap Medical, Inc. is a trailblazer in the Biotechnology, Health Care, Manufacturing, and Pharmaceutical industries. Established in 2011 and headquartered in the United States, the company strives to simplify complex drug delivery through its innovative autoinjector platforms.

Under the banner of "Injecting simplicity into complex drug delivery," Windgap Medical is transforming the patient experience by offering products that liberate users from the constraints of current technology. Their flagship product focuses on adrenaline administration for anaphylaxis, while the development of additional solutions is underway.

The company benefited from a Series B round investment on 20 January 2022, with contributions from investors such as CoBro Ventures, Molex Ventures, Shepherd Kaplan Krochuk, and Taiwania Capital Management Corporation. With its progressive approach and solid investor backing, Windgap Medical is poised to make substantial impacts in drug delivery innovation.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	Undisclosed	4	CoBro Ventures, Molex Ventures +2	20 Jan 2022
Venture Round	$17.00M	-		09 Sep 2021
Grant	$3.20M	1	National Institutes of Health	15 Jan 2020
Corporate Round	Undisclosed	2	Molex Ventures, Shepherd Kaplan Krochuk	25 Jan 2019
Venture Round	$12.15M	-		17 Jan 2019
Convertible Note	Undisclosed	2	Colle Capital, Cherrystone Angel Group	19 Jul 2016
Debt Financing	$2.89M	-		08 Apr 2016
Angel Round	$10.90K	1	Maine Angels	01 Jan 2016
Series A	$4.22M	1	Cherrystone Angel Group	14 Aug 2015
Seed Round	$61.33K	1	Maine Angels	01 Apr 2015

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

Undisclosed

CoBro Ventures, Molex Ventures +2

20 Jan 2022

Venture Round

$17.00M

09 Sep 2021

Grant

$3.20M

National Institutes of Health

15 Jan 2020

Corporate Round

Undisclosed

Molex Ventures, Shepherd Kaplan Krochuk

25 Jan 2019

Venture Round

$12.15M

17 Jan 2019

Convertible Note

Undisclosed

Colle Capital, Cherrystone Angel Group

19 Jul 2016

Debt Financing

$2.89M

08 Apr 2016

Angel Round

$10.90K

Maine Angels

01 Jan 2016

Series A

$4.22M

Cherrystone Angel Group

14 Aug 2015

Seed Round

$61.33K

Maine Angels

01 Apr 2015

FAQ About Windgap Medical, Inc.

Injecting simplicity into complex drug delivery

Windgap Medical, Inc. was founded in 2011.

Windgap Medical, Inc. is headquartered in Watertown, United States.

Windgap Medical, Inc. operates in Biotechnology, Health Care, Manufacturing and Pharmaceutical. Its work centres on biotech, autoinjectors, epinephrine and anaphylaxis treatment. Its customers include Biopharmaceutical Companies, Medical Device Distributors and Healthcare Providers.

Windgap Medical, Inc. has approximately 19 employees.

Windgap Medical, Inc. has completed 14 funding rounds, raising a total of $42.03M. The latest funding stage is Series B.

Windgap Medical, Inc. offers: Development of Autoinjector Platforms, Commercialization of Drug Delivery Devices, Accelerating Complex Drug Administration, Simplifying Medication Delivery Processes, Reducing Environmental Impact in Pharma.

Top alternatives and competitors to Windgap Medical, Inc. include Bryn Pharma, ARS Pharmaceuticals, Inc., DALI Medical Devices Ltd. , TransPharma Medical, Newron Pharmaceuticals SpA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Windgap Medical, Inc. and Bryn Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Windgap Medical, Inc.

Services & Products

Target Customers

Funding Rounds & Investors (14)

Windgap Medical, Inc. Alternatives & Competitors

FAQ About Windgap Medical, Inc.